There is a pressing need to improve the understanding of safety issues during drug development and post-approval. Our interviewees this month explain their roles in efforts to enhance drug safety.
On January 7, 2025, the FDA issued a draft guidance called Considerations for the Use of Artificial Intelligence to Support Regulatory ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback